Introduction
Tablets are one of the most widely used pharmaceutical dosage forms because they are convenient to administer, relatively easy to package, and suitable for producing consistent doses when properly formulated and manufactured.
The tablet manufacturing process involves several carefully controlled stages, beginning with raw material selection and testing and continuing through formulation, blending, granulation where required, compression, coating when applicable, quality testing, and packaging. Each stage helps ensure that finished tablets meet established specifications for identity, strength, quality, and performance.
1. Raw Material Selection and Testing
Tablet production begins with selecting and assessing the materials required for the formulation. Ingredients generally include:
- Active Pharmaceutical Ingredient (API): the ingredient responsible for the intended pharmacological action.
- Binders: help particles adhere and contribute to tablet strength.
- Diluents or fillers: provide suitable bulk and support the required tablet size.
- Disintegrants: help the tablet break apart under specified conditions.
- Lubricants: reduce friction during compression and tablet ejection.
- Glidants: improve powder flow when required.
- Coating materials: provide protective, functional, or appearance-related coatings when needed.
Not every formulation contains all these ingredients. Their selection depends on the API, dosage form, manufacturing process, and intended product performance. Incoming materials should undergo appropriate identification, testing, documentation checks, and quality approval according to established procedures.
2. Weighing and Dispensing
After approval, the required quantities of the API and excipients are weighed according to the approved formulation and batch manufacturing instructions. Accuracy is essential because incorrect quantities can affect product strength, uniformity, and manufacturing performance.
- Verify material identity and batch details.
- Check the approved formulation and dispensing instructions.
- Weigh materials using suitable, calibrated equipment.
- Record the quantities dispensed.
- Maintain appropriate identification and traceability.
- Prevent mix-ups and cross-contamination.
Dispensing should take place under suitable environmental and handling conditions, with appropriate controls for dust and material exposure.
3. Sifting and Sieving
Raw materials may be passed through appropriate sieves to break up agglomerates and achieve the required particle-size distribution. This can help improve consistency before blending or granulation.
The sieve size and processing conditions depend on the formulation and the characteristics of individual ingredients. Sieving is not required in exactly the same form for every product. Equipment cleanliness, material identification, and appropriate controls help prevent contamination and mix-ups.
4. Blending and Mixing
Blending combines the API and selected excipients to produce a sufficiently uniform mixture. The mixing equipment, duration, loading conditions, and sequence of ingredient addition depend on the formulation and process design.
Inadequate blending may contribute to content-uniformity problems, while excessive or unsuitable mixing can adversely affect certain formulations. Manufacturers establish and control suitable blending parameters based on formulation development and process understanding. Where required, blend samples are evaluated using an appropriate sampling and testing strategy.
5. Granulation: Wet or Dry Processing
Granulation is used in many tablet formulations to improve powder flow, compressibility, or other processing characteristics. Some tablets can instead be manufactured using direct compression.
Wet granulation
A suitable granulating liquid or binder solution is added to a powder mixture to form granules. These are processed and dried under controlled conditions before subsequent operations.
Dry granulation
Powders are compacted mechanically, commonly using roller compaction or slugging, and then processed into granules without requiring a granulating liquid.
Direct compression
Suitable powders are blended and compressed directly into tablets without a separate granulation stage, provided their formulation and material properties support this approach.
The appropriate method depends on factors such as API properties, moisture sensitivity, flow characteristics, compressibility, and required product performance.
6. Drying and Milling
For formulations that use wet granulation, the resulting granules generally need controlled drying to achieve suitable moisture levels. Drying parameters must be selected according to the formulation and process requirements; excessive or insufficient drying may affect granule properties and tablet performance.
After drying, granules may be milled or sized to achieve a suitable particle-size distribution. This can support consistent flow, blending, and compression. Drying and milling are not universally required in every tablet manufacturing process.
7. Final Blending and Lubrication
Following granulation and sizing, additional excipients may be blended with the granules. These can include lubricants, glidants, and other formulation components needed to support tablet compression.
The final blend should have appropriate flow and compression characteristics. Mixing conditions must be controlled because the distribution of certain excipients can influence tablet strength, dissolution, and other quality attributes. Before compression, manufacturers verify that the blend is suitable according to established process requirements.
8. Tablet Compression
Tablet compression transforms the prepared powder blend or granules into individual tablets using a tablet press. Material is fed into dies, compressed between punches, and ejected as tablets.
Important process parameters and checks may include:
- Tablet weight and weight variation.
- Compression force.
- Tablet thickness.
- Tablet hardness or crushing strength.
- Tablet appearance and defects.
- Friability, where applicable.
- Equipment performance and process consistency.
Compression settings must be appropriate for the formulation. Excessive compression or unsuitable material properties can contribute to issues such as capping, lamination, or slow disintegration. In-process monitoring helps manufacturers detect problems and take appropriate corrective action.
9. Tablet Coating
Some tablets receive a coating after compression, while others remain uncoated. Coating may improve appearance, protect the tablet surface, facilitate swallowing, mask taste, or provide a functional release characteristic.
Common approaches include film coating and, where appropriate, enteric or other specialized coatings. Coating formulation, equipment settings, temperature, airflow, spray conditions, and process duration must suit the specific product. For products with functional coatings, the process may be particularly important to intended release performance.
10. Quality Control Testing of Finished Tablets
Quality control helps verify that the finished product meets its established specifications. The precise tests depend on the product, applicable pharmacopoeial requirements, approved specifications, and regulatory commitments.
| Test | Purpose |
| Appearance | Checks colour, shape, surface defects, and other visual attributes. |
| Identification | Confirms the identity of the relevant active ingredient. |
| Assay | Determines the amount of active ingredient in the sample. |
| Uniformity of dosage units | Evaluates consistency of drug content or mass as applicable. |
| Dissolution | Measures drug release under specified test conditions. |
| Disintegration | Evaluates how the tablet breaks apart under defined conditions. |
| Friability | Assesses resistance to abrasion and mechanical handling where applicable. |
| Hardness or crushing strength | Helps evaluate mechanical strength. |
| Microbiological testing | Performed when required by the product and applicable specifications. |
Not every test is required for every tablet, and hardness or friability testing does not replace other mandatory release tests. Finished-product release should follow approved quality procedures and applicable regulatory requirements.
11. Packaging and Labelling
Once required quality checks and release procedures are completed, tablets proceed through the applicable packaging and labelling operations. Packaging options may include blister packs, bottles, or other suitable systems.
The packaging system should protect the product against relevant environmental factors, physical damage, and contamination throughout its intended shelf life.
- Verify packaging materials and approved artwork.
- Check product and batch identification.
- Inspect packaging integrity and sealing.
- Ensure accurate labelling and required information.
- Reconcile printed packaging components.
- Maintain batch traceability and packaging records.
Packaging suitability depends on product stability, moisture and light sensitivity, storage conditions, and applicable regulatory requirements.
12. Finished Product Storage and Distribution
Following packaging and batch release, finished products should be stored and distributed under the conditions specified for the product. Appropriate stock rotation, batch traceability, temperature monitoring where required, and distribution records help maintain product integrity throughout the supply chain.
Storage conditions should follow approved product requirements rather than applying a single temperature or humidity standard to all pharmaceutical products.
13. Why Choosing the Right Tablet Manufacturing Partner Matters
Selecting a suitable pharmaceutical manufacturing partner is an important decision for companies developing or expanding their product portfolios. Before entering a manufacturing agreement, businesses should evaluate:
- Manufacturing capabilities and suitable dosage-form experience.
- Applicable manufacturing licences and regulatory compliance.
- Quality management systems and documentation practices.
- Formulation development and technical support capabilities.
- Production capacity and expected lead times.
- Quality-control facilities and testing arrangements.
- Packaging capabilities and supply-chain reliability.
- Commercial terms, minimum batch sizes, and communication processes.
Companies should independently verify relevant certifications, licences, capabilities, and quality arrangements rather than relying solely on marketing claims.
Conclusion
The tablet manufacturing process involves a series of interconnected stages, including raw material testing, weighing, blending, granulation when required, compression, optional coating, quality testing, and packaging. Each stage contributes to the consistency, quality, and performance of the finished product.
Appropriate process controls, qualified materials, trained personnel, and a robust pharmaceutical quality system are essential for reliable manufacturing. For pharmaceutical companies planning a new product or expanding an existing portfolio, choosing a manufacturing partner with suitable technical capabilities and quality systems can support a more effective production strategy.
Call to action: Planning your next pharmaceutical product? Contact Sanctus Global to discuss your pharmaceutical manufacturing requirements, product development needs, and potential manufacturing partnership.
Editorial note: Have Sanctus Global’s technical or quality team review manufacturing details and confirm that the final call to action accurately reflects the services currently offered.